冷干燥血:血液静止和生物物理分析,以控制损伤复苏
Aron A Shoara1,2,3,4, Kanwal Singh2,3,4,5, Henry T Peng5
1Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
冷干燥血 (FDP) 与新鲜血具有可比的静血功能和稳定性. 这使得FDP成为医院前复苏的可行替代方案,克服了后勤方面的挑战.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 生物物理学的生物物理.
背景情况:
- 有效的出血协议需要在出血休克时立即进行静血复苏.
- 使用血液制品进行医院前复苏可以改善结果,但面临物流障碍.
- 冷干燥等离子体 (FDP) 为存储和运输挑战提供了潜在的解决方案.
研究的目的:
- 为了比较冷干燥等离子体 (FDP) 的功能性和结构性质与新鲜等离子体对照.
- 用先进的生物物理技术评估FDP的静血功能和蛋白质稳定性.
主要方法:
- 进行了静血测试.
- 使用了先进的生物物理技术,包括热度计,红外光谱,动态光散射和生物层干扰计.
- 将FDP的功能和结构性质与新鲜血进行了比较.
主要成果:
- FDP显示出与新鲜血形成和凝血参数在很大程度上可比较.
- 经过6个月的储存后,在FDP中没有观察到水分含量的显著变化.
- 生物物理分析显示,在输血期间,FDP的稳定性和带结合亲和性相似.
结论:
- FDP表现出与新鲜血相比的静血功能和蛋白质稳定性.
- FDP是伤害控制复苏的可行替代方案,特别是在医院前和远程环境中.
- 与传统的等离子体相比,FDP提供了显著的后勤和存储优势.
更多相关视频
10:48Isolation and Cryopreservation of Highly Viable Human Peripheral Blood Mononuclear Cells From Whole Blood: A Guide for Beginners
Published on: October 25, 2024
04:10Author Spotlight: Preservation of Bioenergetic Parameters in Peripheral Blood Mononuclear Cells After Cryopreservation
Published on: October 20, 2023
相关概念视频
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
